Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Cabergoline - Generic Drug Details

« Back to Dashboard

What are the generic sources for cabergoline and what is the scope of cabergoline patent protection?

is the generic ingredient in two branded drugs marketed by Apotex Corp, Par Pharm, Actavis Labs Fl Inc, Impax Labs Inc, Mylan Pharms Inc, Ivax Sub Teva Pharms, and Pharmacia And Upjohn, and is included in seven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for cabergoline. Six suppliers are listed for this compound.

Summary for Generic Name: cabergoline

Drug Master File Entries: see list11
Suppliers / Packagers: see list6
Bulk Api Vendors: see list29
Clinical Trials: see list10
Patent Applications: see list3,511
Therapeutic Class:Hormonal Agents, Suppressant (Pituitary)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cabergoline at DailyMed

Pharmacology for Ingredient: cabergoline

Drug ClassErgot Derivative
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc
TABLET;ORAL078035-001Apr 21, 2008ABRXNoNo► Subscribe► Subscribe
Par Pharm
TABLET;ORAL076310-001Dec 29, 2005ABRXNoYes► Subscribe► Subscribe
Mylan Pharms Inc
TABLET;ORAL202947-001Dec 2, 2013ABRXNoNo► Subscribe► Subscribe
Apotex Corp
TABLET;ORAL201503-001Mar 8, 2013ABRXNoNo► Subscribe► Subscribe
Impax Labs Inc
TABLET;ORAL077843-001Jul 3, 2007DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus